Basic info
Industry
research services
Sectors
Biotechnology
Pharmaceutical
drug development
early development
lanthipeptides
receptor agonists
drug discovery
unmet medical need
oncology
critical care medicine
phage display
Therapeutics
peptides
GPCR
stabilized peptides
Date founded
2010
Funding rounds raised
Total raised
$6.2M
from 2 investors over 2 rounds
L
Lanthio Pharma raised $6.2M on November 28, 2012
Investors: Inkef and BGV (BioGeneration Ventures)